FDA Inspection 992250 — Gehring-Montgomery, Inc.
The FDA completed an inspection of Gehring-Montgomery, Inc. on Nov 3, 2016 in Warminster, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 3, 2016
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Warminster, PA (United States)